Company Filing History:
Years Active: 1997-1998
Title: Liming Yu: Innovator in HIV Research
Introduction
Liming Yu is a prominent inventor based in Houston, TX, known for his significant contributions to the field of HIV research. With a total of six patents to his name, he has made strides in developing immunogens and peptides that target critical areas of the HIV virus.
Latest Patents
Among his latest patents is the innovative work on the gC1q receptor and its binding to the HIV-1 gp120 region. This patent discloses immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, as well as immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequences of these binding sites are detailed in SEQ ID NO.: 2 and SEQ ID NO.: 3. Additionally, the patent includes antibodies and binding molecules that can induce the endogenous production of such antibodies, showcasing a potential breakthrough in HIV treatment.
Career Highlights
Liming Yu has worked with notable companies in the biotechnology sector, including Tanox Biosystems, Inc. and Tanux Biosystems, Inc. His work in these organizations has contributed to advancements in immunology and virology.
Collaborations
Throughout his career, Liming Yu has collaborated with esteemed colleagues such as Michael S. Fung and Bill N. Sun. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Liming Yu's contributions to HIV research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical science and potential treatments for HIV.